NeuBase Therapeutics Inc. (NBSE) NASDAQ
$0.43 (0) (-0.83%)
Market Cap: $1.61M
As of 04/19/24 04:00 PM EDT. Market closed.
NeuBase Therapeutics Inc. (NBSE)
NASDAQ
$0.43
(0) (-0.83%)
Market Cap: $1.61M
As of 04/19/24 04:00 PM EDT. Market closed.
Add to Portfolio
neubase has developed a modular antisense technology platform with the capability to address any rare genetic disease caused by mutant proteins with a single, cohesive approach. neubase's platform improves upon gene silencing therapies by combining the advantages of synthetic approaches with the precision of antisense technologies. neubase plans to use its unparalleled antisense platform to ... read more
neubase has developed a modular antisense technology platform with the capability to address any rare genetic disease caused by mutant proteins with a single, cohesive approach. neubase's platform improves upon gene silencing therapies by combining the advantages of synthetic approaches with the precision of antisense technologies. neubase plans to use its unparalleled antisense platform to address both repeat expansion disorders, with an initial focus on huntington's disease and myotonic dystrophy, and dominant genetic disorders. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Dietrich Stephan
Full Time Employees
26
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Dietrich Stephan
Full Time Employees
26
Address
700 Technology Dr, Pennsylvania, Pittsburgh, 15219-3124.
PRICE CHART FOR NEUBASE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.41
Previous Close
$0.43
Days Range
$0.41 - $0.43
52 week range
$0.39 - $4.80
Volume
88,885
Avg. Volume (30 days)
180,044
Market Cap
$1.61M
Dividend Yield
-
P/E
-
Shares Outstanding
3,751,590
Open
$0.41
Previous Close
$0.43
Days Range
$0.41 - $0.43
52 week range
$0.39 - $4.80
Volume
88,885
Avg. Volume (30 days)
180,044
Market Cap
$1.61M
Dividend Yield
-
P/E
-
Shares Outstanding
3,751,590
FINANCIAL STATEMENTS FOR NEUBASE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NEUBASE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Symetryx Corp | 10% Owner | Sep 18, 2023 | Sale | $1.19 | 50,000 | 59,500 | 0 | Sep 18, 2023, 04:32 PM |
| Symetryx Corp | 10% Owner | Sep 15, 2023 | Sale | $1.26 | 103,337 | 130,205 | 50,000 | Sep 18, 2023, 04:32 PM |
| Symetryx Corp | 10% Owner | Sep 14, 2023 | Sale | $1.44 | 129,108 | 185,916 | 153,337 | Sep 18, 2023, 04:32 PM |
| Symetryx Corp | 10% Owner | Sep 11, 2023 | Sale | $1.44 | 3,376 | 4,861 | 472,926 | Sep 11, 2023, 05:08 PM |
| Symetryx Corp | 10% Owner | Sep 08, 2023 | Sale | $1.53 | 128,847 | 197,136 | 476,302 | Sep 11, 2023, 05:08 PM |
| Symetryx Corp | 10% Owner | Sep 07, 2023 | Sale | $1.80 | 74,852 | 134,734 | 605,149 | Sep 11, 2023, 05:08 PM |
| Symetryx Corp | 10% Owner | Sep 01, 2023 | Buy | $0.98 | 61,076 | 59,732 | 680,081 | Sep 07, 2023, 05:19 PM |
| Stephan Dietrich A | Founder and CEO | Aug 02, 2023 | Option Exercise | $0.02 | 93,234 | 2,051 | 93,234 | Aug 04, 2023, 04:39 PM |
| Stephan Dietrich A | CEO | Sep 28, 2022 | Option Exercise | $0.00 | 750,000 | 825 | 816,775 | Sep 30, 2022, 07:45 PM |
| Mann William Roland | Chief Operating Officer | Mar 30, 2022 | Buy | $1.92 | 6,200 | 11,904 | 11,200 | Apr 01, 2022, 04:16 PM |
| Branning Todd P. | Chief Financial Officer | Mar 18, 2022 | Buy | $1.81 | 10,000 | 18,100 | 30,000 | Mar 21, 2022, 04:06 PM |
| Branning Todd P. | Chief Financial Officer | Mar 16, 2022 | Buy | $1.62 | 10,000 | 16,200 | 10,000 | Mar 18, 2022, 04:11 PM |
| Branning Todd P. | Chief Financial Officer | Mar 17, 2022 | Buy | $1.74 | 10,000 | 17,400 | 20,000 | Mar 18, 2022, 04:11 PM |
| RICHMAN ERIC I | Director | Mar 04, 2022 | Buy | $1.62 | 1,000 | 1,620 | 44,960 | Mar 07, 2022, 07:13 PM |
| RICHMAN ERIC I | Director | Mar 03, 2022 | Buy | $1.72 | 1,300 | 2,236 | 43,960 | Mar 07, 2022, 07:13 PM |
| RICHMAN ERIC I | Director | Mar 01, 2022 | Buy | $1.58 | 1,580 | 2,496 | 42,660 | Mar 07, 2022, 07:13 PM |
| Stephan Dietrich A | President and CEO | Dec 31, 2021 | Option Exercise | $0.00 | 42,250 | 42 | 66,775 | Jan 05, 2022, 09:45 PM |
| RICHMAN ERIC I | Director | Apr 26, 2021 | Buy | $5.00 | 5,000 | 25,000 | 41,080 | Apr 27, 2021, 04:03 PM |
| Stephan Dietrich A | President and CEO | Apr 26, 2021 | Buy | $5.00 | 12,000 | 60,000 | 24,525 | Apr 27, 2021, 04:03 PM |
| GOLDSTEIN DOV A MD | Director | Apr 26, 2021 | Buy | $5.00 | 12,000 | 60,000 | 22,000 | Apr 27, 2021, 04:02 PM |
| Mann William Roland | COO | Apr 26, 2021 | Buy | $5.00 | 5,000 | 25,000 | 5,000 | Apr 27, 2021, 04:01 PM |
| Stephan Dietrich A | President and CEO | Jun 09, 2020 | Buy | $7.73 | 1,275 | 9,861 | 12,525 | Jun 10, 2020, 11:50 AM |
| Stephan Dietrich A | President and CEO | May 21, 2020 | Buy | $8.09 | 1,250 | 10,111 | 11,250 | May 26, 2020, 04:39 PM |
| Stephan Dietrich A | President and CEO | Apr 30, 2020 | Buy | $6.00 | 10,000 | 60,000 | 10,000 | May 04, 2020, 03:25 PM |
| GOLDSTEIN DOV A MD | Director | Apr 30, 2020 | Buy | $6.00 | 10,000 | 60,000 | 10,000 | May 04, 2020, 02:18 PM |
| Backenroth Samuel | CFO, Treasurer & Secretary | Apr 30, 2020 | Buy | $6.00 | 1,000 | 6,000 | 11,630 | May 04, 2020, 12:28 PM |
| RICHMAN ERIC I | Director | Apr 30, 2020 | Buy | $6.00 | 8,333 | 49,998 | 36,080 | May 04, 2020, 09:56 AM |
| RICHMAN ERIC I | Director | Apr 30, 2020 | Buy | $6.00 | 2,500 | 15,000 | 27,747 | May 04, 2020, 09:56 AM |
| HIRSCHMAN ORIN | Director | Apr 10, 2017 | Buy | $0.70 | 171,429 | 120,000 | 1,678,177 | Dec 06, 2017, 03:41 PM |
| Slakter Jason Scott | Chief Executive Officer | Apr 10, 2017 | Buy | $0.70 | 142,858 | 100,001 | 1,067,898 | Apr 13, 2017, 02:45 PM |
| Backenroth Samuel | Chief Financial Officer | Apr 10, 2017 | Buy | $0.70 | 71,429 | 50,000 | 212,596 | Apr 13, 2017, 12:59 PM |
| HIRSCHMAN ORIN | Director | Apr 10, 2017 | Buy | $0.70 | 142,858 | 100,001 | 1,649,605 | Apr 13, 2017, 11:11 AM |
| Slakter Jason Scott | Chief Executive Officer | Jun 20, 2016 | Buy | $2.85 | 8,786 | 25,000 | 925,040 | Jun 21, 2016, 12:48 PM |
| Backenroth Samuel | Chief Financial Officer | Jun 20, 2016 | Buy | $2.84 | 2,468 | 6,997 | 141,167 | Jun 21, 2016, 12:41 PM |
| Slakter Jason Scott | Chief Executive Officer | May 25, 2016 | Buy | $3.11 | 3,682 | 11,447 | 916,254 | May 26, 2016, 12:08 PM |
| Slakter Jason Scott | Chief Executive Officer | May 24, 2016 | Buy | $3.09 | 7,503 | 23,178 | 912,572 | May 25, 2016, 01:25 PM |
| Slakter Jason Scott | Chief Executive Officer | May 23, 2016 | Buy | $3.17 | 20,565 | 65,199 | 905,069 | May 25, 2016, 01:25 PM |
| Backenroth Samuel | Chief Financial Officer | May 23, 2016 | Buy | $3.17 | 2,500 | 7,926 | 138,699 | May 24, 2016, 12:39 PM |
| Slakter Jason Scott | Chief Executive Officer | Apr 11, 2016 | Buy | $3.35 | 6,250 | 20,937 | 884,504 | Apr 12, 2016, 01:02 PM |
| Slakter Jason Scott | Chief Executive Officer | Mar 07, 2016 | Buy | $3.63 | 6,250 | 22,669 | 878,254 | Mar 09, 2016, 01:17 PM |
| Slakter Jason Scott | Chief Executive Officer | Feb 22, 2016 | Buy | $3.11 | 6,250 | 19,431 | 872,004 | Feb 23, 2016, 01:25 PM |
| Slakter Jason Scott | Chief Executive Officer | Jan 19, 2016 | Buy | $3.62 | 6,250 | 22,606 | 865,754 | Jan 20, 2016, 10:33 AM |
| Slakter Jason Scott | Chief Executive Officer | Dec 07, 2015 | Buy | $4.07 | 3,000 | 12,219 | 509,146 | Dec 08, 2015, 02:37 PM |
| Slakter Jason Scott | Chief Executive Officer | Nov 03, 2015 | Buy | $3.01 | 100 | 301 | 77,923 | Nov 04, 2015, 01:32 PM |
| Slakter Jason Scott | Chief Executive Officer | Nov 02, 2015 | Buy | $3.00 | 13,250 | 39,738 | 77,823 | Nov 04, 2015, 01:32 PM |
| Backenroth Samuel | Chief Financial Officer | Feb 06, 2015 | Buy | $6.75 | 1,500 | 10,125 | 6,199 | Feb 10, 2015, 03:55 PM |
| Slakter Jason Scott | Director | Feb 06, 2015 | Buy | $6.75 | 29,630 | 200,003 | 64,573 | Feb 10, 2015, 03:48 PM |
| Taraporewala Irach B. | Chief Executive Officer | Feb 06, 2015 | Buy | $6.75 | 3,705 | 25,009 | 22,800 | Feb 10, 2015, 12:50 PM |
| Almenoff June Sherie | Director | Feb 06, 2015 | Buy | $6.75 | 6,000 | 40,500 | 16,900 | Feb 10, 2015, 12:46 PM |
| GREENSTEIN IRA A | Director | Jan 15, 2015 | Option Exercise | $1.65 | 54,659 | 90,187 | 431,051 | Jan 16, 2015, 02:21 PM |
| HIRSCHMAN ORIN | Director | Sep 08, 2014 | Option Exercise | $6.75 | 71,888 | 485,244 | 1,750,748 | Sep 10, 2014, 05:56 PM |
| GREENSTEIN IRA A | Director | Sep 08, 2014 | Option Exercise | $6.75 | 6,123 | 41,330 | 443,059 | Sep 10, 2014, 05:51 PM |
| Almenoff June Sherie | Director | Sep 03, 2014 | Buy | $8.05 | 1,200 | 9,660 | 127,566 | Sep 04, 2014, 01:10 PM |
| Almenoff June Sherie | Director | Sep 02, 2014 | Buy | $8.12 | 1,000 | 8,120 | 126,366 | Sep 04, 2014, 01:10 PM |
| GREENSTEIN IRA A | Director | Jul 02, 2014 | Buy | $8.40 | 1,000 | 8,400 | 456,496 | Jul 03, 2014, 11:28 AM |
| Almenoff June Sherie | Director | Jun 26, 2014 | Buy | $8.34 | 3,200 | 26,688 | 125,366 | Jun 30, 2014, 03:41 PM |
| Riedhammer Thomas M | Director | Jun 25, 2014 | Buy | $7.39 | 6,900 | 50,991 | 124,667 | Jun 27, 2014, 08:00 PM |
| Riedhammer Thomas M | Director | Apr 10, 2014 | Buy | $10.36 | 1,100 | 11,396 | 117,767 | Apr 21, 2014, 10:55 AM |
| GREENSTEIN IRA A | Director | Apr 09, 2014 | Buy | $10.20 | 2,500 | 25,500 | 455,496 | Apr 10, 2014, 01:02 PM |
| Almenoff June Sherie | Director | Apr 08, 2014 | Buy | $10.25 | 5,500 | 56,375 | 122,166 | Apr 09, 2014, 03:28 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Symetryx Corp | 10% Owner | 09/18/2023 | 59,500 |
| Symetryx Corp | 10% Owner | 09/15/2023 | 130,205 |
| Symetryx Corp | 10% Owner | 09/14/2023 | 185,916 |
| Symetryx Corp | 10% Owner | 09/11/2023 | 4,861 |
| Symetryx Corp | 10% Owner | 09/08/2023 | 197,136 |
| Symetryx Corp | 10% Owner | 09/07/2023 | 134,734 |
| Symetryx Corp | 10% Owner | 09/01/2023 | 59,732 |
| Stephan Dietrich A | Founder and CEO | 08/02/2023 | 2,051 |
| Stephan Dietrich A | CEO | 09/28/2022 | 825 |
| Mann William Roland | Chief Operating Officer | 03/30/2022 | 11,904 |
| Branning Todd P. | Chief Financial Officer | 03/18/2022 | 18,100 |
| Branning Todd P. | Chief Financial Officer | 03/16/2022 | 16,200 |
| Branning Todd P. | Chief Financial Officer | 03/17/2022 | 17,400 |
| RICHMAN ERIC I | Director | 03/04/2022 | 1,620 |
| RICHMAN ERIC I | Director | 03/03/2022 | 2,236 |
| RICHMAN ERIC I | Director | 03/01/2022 | 2,496 |
| Stephan Dietrich A | President and CEO | 12/31/2021 | 42 |
| RICHMAN ERIC I | Director | 04/26/2021 | 25,000 |
| Stephan Dietrich A | President and CEO | 04/26/2021 | 60,000 |
| GOLDSTEIN DOV A MD | Director | 04/26/2021 | 60,000 |
| Mann William Roland | COO | 04/26/2021 | 25,000 |
| Stephan Dietrich A | President and CEO | 06/09/2020 | 9,861 |
| Stephan Dietrich A | President and CEO | 05/21/2020 | 10,111 |
| Stephan Dietrich A | President and CEO | 04/30/2020 | 60,000 |
| GOLDSTEIN DOV A MD | Director | 04/30/2020 | 60,000 |
| Backenroth Samuel | CFO, Treasurer & Secretary | 04/30/2020 | 6,000 |
| RICHMAN ERIC I | Director | 04/30/2020 | 49,998 |
| RICHMAN ERIC I | Director | 04/30/2020 | 15,000 |
| HIRSCHMAN ORIN | Director | 04/10/2017 | 120,000 |
| Slakter Jason Scott | Chief Executive Officer | 04/10/2017 | 100,001 |
| Backenroth Samuel | Chief Financial Officer | 04/10/2017 | 50,000 |
| HIRSCHMAN ORIN | Director | 04/10/2017 | 100,001 |
| Slakter Jason Scott | Chief Executive Officer | 06/20/2016 | 25,000 |
| Backenroth Samuel | Chief Financial Officer | 06/20/2016 | 6,997 |
| Slakter Jason Scott | Chief Executive Officer | 05/25/2016 | 11,447 |
| Slakter Jason Scott | Chief Executive Officer | 05/24/2016 | 23,178 |
| Slakter Jason Scott | Chief Executive Officer | 05/23/2016 | 65,199 |
| Backenroth Samuel | Chief Financial Officer | 05/23/2016 | 7,926 |
| Slakter Jason Scott | Chief Executive Officer | 04/11/2016 | 20,937 |
| Slakter Jason Scott | Chief Executive Officer | 03/07/2016 | 22,669 |
| Slakter Jason Scott | Chief Executive Officer | 02/22/2016 | 19,431 |
| Slakter Jason Scott | Chief Executive Officer | 01/19/2016 | 22,606 |
| Slakter Jason Scott | Chief Executive Officer | 12/07/2015 | 12,219 |
| Slakter Jason Scott | Chief Executive Officer | 11/03/2015 | 301 |
| Slakter Jason Scott | Chief Executive Officer | 11/02/2015 | 39,738 |
| Backenroth Samuel | Chief Financial Officer | 02/06/2015 | 10,125 |
| Slakter Jason Scott | Director | 02/06/2015 | 200,003 |
| Taraporewala Irach B. | Chief Executive Officer | 02/06/2015 | 25,009 |
| Almenoff June Sherie | Director | 02/06/2015 | 40,500 |
| GREENSTEIN IRA A | Director | 01/15/2015 | 90,187 |
| HIRSCHMAN ORIN | Director | 09/08/2014 | 485,244 |
| GREENSTEIN IRA A | Director | 09/08/2014 | 41,330 |
| Almenoff June Sherie | Director | 09/03/2014 | 9,660 |
| Almenoff June Sherie | Director | 09/02/2014 | 8,120 |
| GREENSTEIN IRA A | Director | 07/02/2014 | 8,400 |
| Almenoff June Sherie | Director | 06/26/2014 | 26,688 |
| Riedhammer Thomas M | Director | 06/25/2014 | 50,991 |
| Riedhammer Thomas M | Director | 04/10/2014 | 11,396 |
| GREENSTEIN IRA A | Director | 04/09/2014 | 25,500 |
| Almenoff June Sherie | Director | 04/08/2014 | 56,375 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NEUBASE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GREENLIGHT CAPITAL INC | 136,350 | 0.00493% | No change | Activists |
| RENAISSANCE TECHNOLOGIES LLC | 56,967 | 0.00007% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 15,482 | 0% | No change | Other |
| BLACKROCK INC. | 84 | 0% | -80.91% | Other |
CHANGE IN SHARES OUTSTANDING FOR NEUBASE THERAPEUTICS INC
STOCK BUYBACKS FOR NEUBASE THERAPEUTICS INC
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2022
70.97%
5Q
03/31/2022
68.75%
6Q
12/31/2021
68.53%
7Q
06/30/2021
83.27%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR NEUBASE THERAPEUTICS INC
LOADING...